This is a strategic but early-stage reimbursement initiative with no near-term revenue catalyst. Monitor for U.S. payer coverage decisions and scan volume data in future filings to gauge commercial traction.
Price Chart
Executive Summary
Aclarion announced a Market Access Program with PRIA Healthcare to pursue U.S. payer coverage and reimbursement for its Nociscan AI platform for chronic low back pain. The partnership aims to build on prior UK reimbursement wins, but no financial terms, revenue impact, or near-term revenue guidance were disclosed.
Key Facts
- Aclarion launched a Market Access Program with PRIA Healthcare to advance U.S. reimbursement for Nociscan.
- PRIA will provide payer engagement, prior authorization support, and appeals management.
- Nociscan has payer approval from three of the top four private insurers in the UK.
- No financial terms, revenue projections, or timeline for U.S. coverage were disclosed.
Financial Impact
No financial figures disclosed; program is pre-revenue and reimbursement-dependent.
Risk Factors
- U.S. payer coverage may be delayed or denied, limiting commercial adoption.
- No disclosed financial terms or revenue impact from the partnership.
- Aclarion has a micro-cap market cap ($8M) and limited cash runway, increasing execution risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3308684 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 9w ago | Insider Cluster | $2.77 $2.64 | ▼ −4.69% | ▼ −2.74% | $1.97 (−28.75%) |
Aug 18, 2026 9w ago | Insider Cluster | $2.60 $2.53 | ▼ −2.67% | ▼ −1.68% | $1.97 (−24.10%) |
Jun 9, 2026 19w ago | Press Release | $3.26 $2.99 | ▼ −8.28% | ▼ −9.73% | $1.97 (−39.46%) |
Jun 8, 2026 20w ago | Press Release | $3.36 $3.07 | ▼ −8.63% | ▼ −10.26% | $1.97 (−41.26%) |
Jun 3, 2026 20w ago | Press Release | $3.49 $3.09 | ▼ −11.46% | ▼ −10.46% | $1.97 (−43.45%) |
Jun 1, 2026 21w ago | Press Release | $3.37 $2.88 | ▼ −14.54% | ▼ −13.24% | $1.97 (−41.44%) |
May 6, 2026 24w ago | Insider Cluster | $3.28 $3.49 | ▲ +6.40% | ▲ +3.62% | $1.97 (−39.83%) |
May 5, 2026 24w ago | Press Release | $3.20 $3.50 | ▲ +9.38% | ▲ +4.42% | $1.97 (−38.33%) |
Apr 22, 2026 26w ago | Press Release | $3.73 $3.20 | ▼ −14.21% | ▼ −17.37% | $1.97 (−47.09%) |
Mar 19, 2026 31w ago | Press Release | $3.26 $3.39 | ▲ +3.99% | ▼ −3.63% | $1.97 (−39.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers